Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K
Research Group for Pharmaceutical Activities of Natural Products using Pharmaceutical Biotechnology (PANPB), Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Faculty of Veterinary Medicine and Applied Zoology, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand.
J Physiol Pharmacol. 2021 Jun;72(3). doi: 10.26402/jpp.2021.3.11. Epub 2021 Dec 3.
Anti-inflammatory and antioxidant effects of Garcinia mangostana (GM) and α-mangostin (MGS) on dextran sulfate sodium (DSS)-induced hepatotoxicity were examined. Male Institute of Cancer Research (ICR) mice were orally administered GM (40, 200, and 1000 mg/kg/day), MGS (30 mg/kg/day), or sulfasalazine (100 mg/kg/day) for 7 days. Hepatic injury was induced by oral administration of DSS (40 kDa, 6 g/kg/day) on days 4 - 7. Colitis disease activity index (DAI) and serum aspartate aminotransferase/alanine aminotransferase (AST/ALT) were determined on day 7. The livers were removed for histological analysis by hematoxylin and eosin staining, and for determination of myeloperoxidase (MPO) activity, malondialdehyde (MDA) and nitric oxide (NO) levels, and superoxide dismutase (SOD) and catalase (CAT) activities. Expression of inflammatory associated genes, including pro-inflammatory cytokines tumor necrosis factor α (Tnfα) and interleukin 1 beta (Il1β), vascular and intercellular adhesion molecules (Vcam1 and Icam1), chemokine (C-C motif) ligand 2 (Ccl2), nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (Nfkb1), nuclear factor erythroid derived 2 like 2 (Nfe2l2), and toll-like receptor 2 and 4 (Tlr2 and Tlr4) were examined by RT-qPCR. DSS-induced hepatic histopathological changes (cell membrane disruption, pyknotic nuclei, and necrotic areas) corresponded with increases in DAI, serum AST and ALT, MPO activity, and MDA and NO levels, and decreases in SOD and CAT activities. GM and MGS prevented DSS-induced hepatic histopathological changes, reduced MPO activity and MDA and NO levels, and enhanced SOD and CAT activities. GM and MGS prevented DSS-induced upregulation of Tnfα, Il1β, Vcam1, Icam1, Ccl2, Nfkb1, and Tlr4. Sulfasalazine did not indicate any improvement. GM and MGS ameliorated DSS-induced hepatotoxicity via suppression of inflammatory and oxidative responses.
研究了山竹果(GM)和α-倒捻子素(MGS)对葡聚糖硫酸钠(DSS)诱导的肝毒性的抗炎和抗氧化作用。将雄性癌症研究所(ICR)小鼠口服给予GM(40、200和1000mg/kg/天)、MGS(30mg/kg/天)或柳氮磺胺吡啶(100mg/kg/天),持续7天。在第4至7天通过口服给予DSS(40kDa,6g/kg/天)诱导肝损伤。在第7天测定结肠炎疾病活动指数(DAI)和血清天冬氨酸氨基转移酶/丙氨酸氨基转移酶(AST/ALT)。取出肝脏,通过苏木精和伊红染色进行组织学分析,并测定髓过氧化物酶(MPO)活性、丙二醛(MDA)和一氧化氮(NO)水平以及超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性。通过RT-qPCR检测炎症相关基因的表达,包括促炎细胞因子肿瘤坏死因子α(Tnfα)和白细胞介素1β(Il1β)、血管和细胞间粘附分子(Vcam1和Icam1)、趋化因子(C-C基序)配体2(Ccl2)、B细胞中κ轻链多肽基因增强子的核因子1(Nfkb1)、核因子红细胞衍生2样2(Nfe2l2)以及Toll样受体2和4(Tlr2和Tlr4)。DSS诱导肝组织病理学变化(细胞膜破坏、固缩核和坏死区域)与DAI、血清AST和ALT、MPO活性以及MDA和NO水平升高以及SOD和CAT活性降低相对应。GM和MGS可预防DSS诱导的肝组织病理学变化,降低MPO活性以及MDA和NO水平,并增强SOD和CAT活性。GM和MGS可预防DSS诱导的Tnfα、Il1β、Vcam1、Icam1、Ccl2、Nfkb1和Tlr4上调。柳氮磺胺吡啶未显示出任何改善作用。GM和MGS通过抑制炎症和氧化反应改善DSS诱导的肝毒性。